Predictive value of surveillance cultures for bacteremia caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales among patients with hematological diseases View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-01-10

AUTHORS

Takuya Hattori, Tatsunori Goto, Masahide Osaki, Yukiyasu Ozawa, Koichi Miyamura

ABSTRACT

PurposeDue to the increasing prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, empirical therapies with cefepime or piperacillin/tazobactam for hematology patients with febrile neutropenia have become ineffective. Carbapenems should be administered as soon as possible in such patients with ESBL bacteremia. If the surveillance culture results are consistent with the blood culture findings, the time to adequate treatment initiation can be shortened.MethodsAll consecutive patients with Enterobacterales bacteraemia who were admitted from January 2013 to December 2018 at the hematology wards were enrolled in this study. Surveillance rectal swab and blood culture results were compared.ResultsIn total, 67 patients with Enterobacterales bacteremia underwent surveillance culture prior to the onset of infection. Regarding the presence or absence of ESBL-producing Enterobacterales, 64 (95.5%) patients had surveillance results concordant with blood culture results. The positive predictive value of surveillance culture for bacteremia caused by ESBL-producing Enterobacterales was 95.0%. Moreover, the negative predictive value of surveillance culture for bacteremia caused by non-ESBL-producing Enterobacterales was 95.7%.ConclusionThe concordance rate between the surveillance rectal swab and blood cultures was highly acceptable. Surveillance rectal swab cultures are useful for identifying patients at high risk for ESBL bacteremia. More... »

PAGES

753-759

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s15010-021-01753-z

DOI

http://dx.doi.org/10.1007/s15010-021-01753-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1144552772

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35013943


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bacteremia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Escherichia coli", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematologic Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "beta-Lactamases", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical Laboratory, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, 453-8511, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Clinical Laboratory, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, 453-8511, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hattori", 
        "givenName": "Takuya", 
        "id": "sg:person.0631270770.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631270770.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goto", 
        "givenName": "Tatsunori", 
        "id": "sg:person.01302140507.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302140507.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Osaki", 
        "givenName": "Masahide", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ozawa", 
        "givenName": "Yukiyasu", 
        "id": "sg:person.01165712107.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165712107.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyamura", 
        "givenName": "Koichi", 
        "id": "sg:person.01273257010.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273257010.61"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bmt.2012.244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028358194", 
          "https://doi.org/10.1038/bmt.2012.244"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-010-0923-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036728311", 
          "https://doi.org/10.1007/s00520-010-0923-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s005209900095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074582567", 
          "https://doi.org/10.1007/s005209900095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-008-1247-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050238555", 
          "https://doi.org/10.1007/s00134-008-1247-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11864-019-0693-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124031642", 
          "https://doi.org/10.1007/s11864-019-0693-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-010-1146-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052878799", 
          "https://doi.org/10.1007/s10096-010-1146-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s15010-013-0525-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000105305", 
          "https://doi.org/10.1007/s15010-013-0525-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-018-3423-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105310251", 
          "https://doi.org/10.1007/s00277-018-3423-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-011-1247-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043912835", 
          "https://doi.org/10.1007/s00277-011-1247-7"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-01-10", 
    "datePublishedReg": "2022-01-10", 
    "description": "PurposeDue to the increasing prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, empirical therapies with cefepime or piperacillin/tazobactam for hematology patients with febrile neutropenia have become ineffective. Carbapenems should be administered as soon as possible in such patients with ESBL bacteremia. If the surveillance culture results are consistent with the blood culture findings, the time to adequate treatment initiation can be shortened.MethodsAll consecutive patients with Enterobacterales bacteraemia who were admitted from January 2013 to December 2018 at the hematology wards were enrolled in this study. Surveillance rectal swab and blood culture results were compared.ResultsIn total, 67 patients with Enterobacterales bacteremia underwent surveillance culture prior to the onset of infection. Regarding the presence or absence of ESBL-producing Enterobacterales, 64 (95.5%) patients had surveillance results concordant with blood culture results. The positive predictive value of surveillance culture for bacteremia caused by ESBL-producing Enterobacterales was 95.0%. Moreover, the negative predictive value of surveillance culture for bacteremia caused by non-ESBL-producing Enterobacterales was 95.7%.ConclusionThe concordance rate between the surveillance rectal swab and blood cultures was highly acceptable. Surveillance rectal swab cultures are useful for identifying patients at high risk for ESBL bacteremia.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s15010-021-01753-z", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1016707", 
        "issn": [
          "0300-8126", 
          "1439-0973"
        ], 
        "name": "Infection", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "50"
      }
    ], 
    "keywords": [
      "ESBL-producing Enterobacterales", 
      "blood culture results", 
      "surveillance rectal swabs", 
      "surveillance cultures", 
      "predictive value", 
      "culture results", 
      "ESBL bacteremia", 
      "rectal swabs", 
      "MethodsAll consecutive patients", 
      "blood culture findings", 
      "piperacillin/tazobactam", 
      "rectal swab cultures", 
      "surveillance culture results", 
      "onset of infection", 
      "negative predictive value", 
      "positive predictive value", 
      "febrile neutropenia", 
      "Enterobacterales bacteremia", 
      "empirical therapy", 
      "hematology patients", 
      "such patients", 
      "treatment initiation", 
      "consecutive patients", 
      "hematology ward", 
      "ResultsIn total", 
      "blood cultures", 
      "swab cultures", 
      "bacteremia", 
      "high risk", 
      "patients", 
      "hematological diseases", 
      "culture findings", 
      "concordance rate", 
      "surveillance results", 
      "Enterobacterales", 
      "swabs", 
      "neutropenia", 
      "bacteraemia", 
      "tazobactam", 
      "therapy", 
      "cefepime", 
      "infection", 
      "prevalence", 
      "carbapenems", 
      "wards", 
      "disease", 
      "PurposeDue", 
      "total", 
      "risk", 
      "onset", 
      "culture", 
      "initiation", 
      "findings", 
      "absence", 
      "results", 
      "study", 
      "rate", 
      "presence", 
      "values", 
      "time"
    ], 
    "name": "Predictive value of surveillance cultures for bacteremia caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales among patients with hematological diseases", 
    "pagination": "753-759", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1144552772"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s15010-021-01753-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35013943"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s15010-021-01753-z", 
      "https://app.dimensions.ai/details/publication/pub.1144552772"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_955.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s15010-021-01753-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s15010-021-01753-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s15010-021-01753-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s15010-021-01753-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s15010-021-01753-z'


 

This table displays all metadata directly associated to this object as RDF triples.

214 TRIPLES      21 PREDICATES      101 URIs      84 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s15010-021-01753-z schema:about N1fcd693b2204492a88b257193d236f4f
2 N38f2665c0cd84656a27486e937684339
3 N784f67edb8a14117bbee0af13b8e4420
4 N989e2d2adaf44ed49525eec8b6ee6da4
5 Nc1aab3eddf7640789b5cd8e7a5b96091
6 Nc8b1c858ae8f40f1904488ca94a816f0
7 Nd60b0a9b28f04258a4df0adc47cd0d67
8 anzsrc-for:11
9 anzsrc-for:1103
10 schema:author N6417ff5476a547979b75cbcadbb66774
11 schema:citation sg:pub.10.1007/s00134-008-1247-9
12 sg:pub.10.1007/s00277-011-1247-7
13 sg:pub.10.1007/s00277-018-3423-5
14 sg:pub.10.1007/s00520-010-0923-9
15 sg:pub.10.1007/s005209900095
16 sg:pub.10.1007/s10096-010-1146-1
17 sg:pub.10.1007/s11864-019-0693-7
18 sg:pub.10.1007/s15010-013-0525-9
19 sg:pub.10.1038/bmt.2012.244
20 schema:datePublished 2022-01-10
21 schema:datePublishedReg 2022-01-10
22 schema:description PurposeDue to the increasing prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, empirical therapies with cefepime or piperacillin/tazobactam for hematology patients with febrile neutropenia have become ineffective. Carbapenems should be administered as soon as possible in such patients with ESBL bacteremia. If the surveillance culture results are consistent with the blood culture findings, the time to adequate treatment initiation can be shortened.MethodsAll consecutive patients with Enterobacterales bacteraemia who were admitted from January 2013 to December 2018 at the hematology wards were enrolled in this study. Surveillance rectal swab and blood culture results were compared.ResultsIn total, 67 patients with Enterobacterales bacteremia underwent surveillance culture prior to the onset of infection. Regarding the presence or absence of ESBL-producing Enterobacterales, 64 (95.5%) patients had surveillance results concordant with blood culture results. The positive predictive value of surveillance culture for bacteremia caused by ESBL-producing Enterobacterales was 95.0%. Moreover, the negative predictive value of surveillance culture for bacteremia caused by non-ESBL-producing Enterobacterales was 95.7%.ConclusionThe concordance rate between the surveillance rectal swab and blood cultures was highly acceptable. Surveillance rectal swab cultures are useful for identifying patients at high risk for ESBL bacteremia.
23 schema:genre article
24 schema:isAccessibleForFree false
25 schema:isPartOf N34817b77914f4907b11d7c00da5d2168
26 N8d95eaf1ab7942388b35dba401cf8bf7
27 sg:journal.1016707
28 schema:keywords ESBL bacteremia
29 ESBL-producing Enterobacterales
30 Enterobacterales
31 Enterobacterales bacteremia
32 MethodsAll consecutive patients
33 PurposeDue
34 ResultsIn total
35 absence
36 bacteraemia
37 bacteremia
38 blood culture findings
39 blood culture results
40 blood cultures
41 carbapenems
42 cefepime
43 concordance rate
44 consecutive patients
45 culture
46 culture findings
47 culture results
48 disease
49 empirical therapy
50 febrile neutropenia
51 findings
52 hematological diseases
53 hematology patients
54 hematology ward
55 high risk
56 infection
57 initiation
58 negative predictive value
59 neutropenia
60 onset
61 onset of infection
62 patients
63 piperacillin/tazobactam
64 positive predictive value
65 predictive value
66 presence
67 prevalence
68 rate
69 rectal swab cultures
70 rectal swabs
71 results
72 risk
73 study
74 such patients
75 surveillance culture results
76 surveillance cultures
77 surveillance rectal swabs
78 surveillance results
79 swab cultures
80 swabs
81 tazobactam
82 therapy
83 time
84 total
85 treatment initiation
86 values
87 wards
88 schema:name Predictive value of surveillance cultures for bacteremia caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales among patients with hematological diseases
89 schema:pagination 753-759
90 schema:productId N75944b5b52744978ab4b608d264f6af3
91 N8632c86797024acc98832a768458cb1f
92 Ndf4c7705e76d411784906ebbd6c28626
93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1144552772
94 https://doi.org/10.1007/s15010-021-01753-z
95 schema:sdDatePublished 2022-12-01T06:45
96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
97 schema:sdPublisher Nefbab14db1ac4a619f60aee449f82bd3
98 schema:url https://doi.org/10.1007/s15010-021-01753-z
99 sgo:license sg:explorer/license/
100 sgo:sdDataset articles
101 rdf:type schema:ScholarlyArticle
102 N1fcd693b2204492a88b257193d236f4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Anti-Bacterial Agents
104 rdf:type schema:DefinedTerm
105 N34817b77914f4907b11d7c00da5d2168 schema:volumeNumber 50
106 rdf:type schema:PublicationVolume
107 N38f2665c0cd84656a27486e937684339 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Retrospective Studies
109 rdf:type schema:DefinedTerm
110 N3eb6b1b10c1c4bf7928e8e24799fd004 rdf:first sg:person.01302140507.61
111 rdf:rest Ndf39f40e38f34e4dac256ee7af8def40
112 N6417ff5476a547979b75cbcadbb66774 rdf:first sg:person.0631270770.36
113 rdf:rest N3eb6b1b10c1c4bf7928e8e24799fd004
114 N65db0d1ef44046ba8eb96e89c2c3b98a rdf:first sg:person.01273257010.61
115 rdf:rest rdf:nil
116 N75944b5b52744978ab4b608d264f6af3 schema:name doi
117 schema:value 10.1007/s15010-021-01753-z
118 rdf:type schema:PropertyValue
119 N784f67edb8a14117bbee0af13b8e4420 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Bacteremia
121 rdf:type schema:DefinedTerm
122 N8632c86797024acc98832a768458cb1f schema:name pubmed_id
123 schema:value 35013943
124 rdf:type schema:PropertyValue
125 N8d95eaf1ab7942388b35dba401cf8bf7 schema:issueNumber 3
126 rdf:type schema:PublicationIssue
127 N989e2d2adaf44ed49525eec8b6ee6da4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Humans
129 rdf:type schema:DefinedTerm
130 Naeba82afe7054398909e2b45fd94f919 rdf:first sg:person.01165712107.72
131 rdf:rest N65db0d1ef44046ba8eb96e89c2c3b98a
132 Nc1aab3eddf7640789b5cd8e7a5b96091 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name beta-Lactamases
134 rdf:type schema:DefinedTerm
135 Nc8b1c858ae8f40f1904488ca94a816f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Escherichia coli
137 rdf:type schema:DefinedTerm
138 Ncdab6701d6c34449b4f2ef99855d7bc2 schema:affiliation grid-institutes:None
139 schema:familyName Osaki
140 schema:givenName Masahide
141 rdf:type schema:Person
142 Nd60b0a9b28f04258a4df0adc47cd0d67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Hematologic Diseases
144 rdf:type schema:DefinedTerm
145 Ndf39f40e38f34e4dac256ee7af8def40 rdf:first Ncdab6701d6c34449b4f2ef99855d7bc2
146 rdf:rest Naeba82afe7054398909e2b45fd94f919
147 Ndf4c7705e76d411784906ebbd6c28626 schema:name dimensions_id
148 schema:value pub.1144552772
149 rdf:type schema:PropertyValue
150 Nefbab14db1ac4a619f60aee449f82bd3 schema:name Springer Nature - SN SciGraph project
151 rdf:type schema:Organization
152 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
153 schema:name Medical and Health Sciences
154 rdf:type schema:DefinedTerm
155 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
156 schema:name Clinical Sciences
157 rdf:type schema:DefinedTerm
158 sg:journal.1016707 schema:issn 0300-8126
159 1439-0973
160 schema:name Infection
161 schema:publisher Springer Nature
162 rdf:type schema:Periodical
163 sg:person.01165712107.72 schema:affiliation grid-institutes:None
164 schema:familyName Ozawa
165 schema:givenName Yukiyasu
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165712107.72
167 rdf:type schema:Person
168 sg:person.01273257010.61 schema:affiliation grid-institutes:None
169 schema:familyName Miyamura
170 schema:givenName Koichi
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273257010.61
172 rdf:type schema:Person
173 sg:person.01302140507.61 schema:affiliation grid-institutes:None
174 schema:familyName Goto
175 schema:givenName Tatsunori
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302140507.61
177 rdf:type schema:Person
178 sg:person.0631270770.36 schema:affiliation grid-institutes:None
179 schema:familyName Hattori
180 schema:givenName Takuya
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631270770.36
182 rdf:type schema:Person
183 sg:pub.10.1007/s00134-008-1247-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050238555
184 https://doi.org/10.1007/s00134-008-1247-9
185 rdf:type schema:CreativeWork
186 sg:pub.10.1007/s00277-011-1247-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043912835
187 https://doi.org/10.1007/s00277-011-1247-7
188 rdf:type schema:CreativeWork
189 sg:pub.10.1007/s00277-018-3423-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105310251
190 https://doi.org/10.1007/s00277-018-3423-5
191 rdf:type schema:CreativeWork
192 sg:pub.10.1007/s00520-010-0923-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036728311
193 https://doi.org/10.1007/s00520-010-0923-9
194 rdf:type schema:CreativeWork
195 sg:pub.10.1007/s005209900095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074582567
196 https://doi.org/10.1007/s005209900095
197 rdf:type schema:CreativeWork
198 sg:pub.10.1007/s10096-010-1146-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052878799
199 https://doi.org/10.1007/s10096-010-1146-1
200 rdf:type schema:CreativeWork
201 sg:pub.10.1007/s11864-019-0693-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124031642
202 https://doi.org/10.1007/s11864-019-0693-7
203 rdf:type schema:CreativeWork
204 sg:pub.10.1007/s15010-013-0525-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000105305
205 https://doi.org/10.1007/s15010-013-0525-9
206 rdf:type schema:CreativeWork
207 sg:pub.10.1038/bmt.2012.244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028358194
208 https://doi.org/10.1038/bmt.2012.244
209 rdf:type schema:CreativeWork
210 grid-institutes:None schema:alternateName Department of Clinical Laboratory, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, 453-8511, Nagoya, Japan
211 Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
212 schema:name Department of Clinical Laboratory, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, 453-8511, Nagoya, Japan
213 Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
214 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...